Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pentoxifylline Dose Optimization in Preterm Neonatal Late Onset Sepsis

Next Previous
Search
Trial Profile

Pentoxifylline Dose Optimization in Preterm Neonatal Late Onset Sepsis

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pentoxifylline (Primary)
  • Indications Neonatal infections
  • Focus Adverse reactions

    • Most Recent Events

    • 08 Aug 2024 Status changed from recruiting to completed.
    • 19 Jun 2023 This trial has been completed in Poland, according to European Clinical Trials Database record.
    • 21 Jun 2022 Planned End Date changed from 1 Jan 2021 to 1 Dec 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top